Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020
We confirmed a stable incidence of pediatric NETs during the study period. The overall recurrence rate was 0.5% and no NET-related mortality was observed. Known genetic predisposition was present in 1.8% of patients. Future guidelines should consider the apparent indolent nature and excellent prognosis of these tumors.
Authors
- Lene Gaarsmand Christensen (ORCID: https://orcid.org/0000-0002-4287-9848)
- Mathias Rathe (ORCID: https://orcid.org/0000-0002-7533-3112)
- Pernille Holmager (ORCID: https://orcid.org/0000-0002-2133-5980)
- Ulrich Knigge (ORCID: https://orcid.org/0000-0001-5930-0903)
- Sören Möller (ORCID: https://orcid.org/0000-0003-0858-4269)
- Mark Bremholm Ellebæk (ORCID: https://orcid.org/0000-0001-6550-7505)
- Mona P. Ankerstjerne
- Sara Giovannoni
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Rigshospitalet (DK)
- European Neuroendocrine Tumor Society (DE)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1002/pbc.31420
- Citations
- 8
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 3.09
Funders
- Børnecancerfonden
- Odense Universitetshospital